Capsulomics, Inc.

Amendment

CIK: 0001800623·Biotechnology·MARYLAND·Filed: Mar 19, 2025

Total Offering

$3,000,000

Amount Sold

$2,392,270

Investors

10

First Sale

Dec 17, 2019

Offering Details

Type: Other: Simple Agreement for Future Equity [SAFE]
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Daniel Lunz	Related Person
Stephen Meltzer	Related Person
John Neiderhuber	Related Person
William Stevens	Related Person

Company

Capsulomics, Inc.

1450 S ROLLING ROAD

HALETHORPE, MD, 21227

8778444487

SEC Filing

0001800623-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.